- Home
- ABNB vs SNY Comparison
ABNB vs SNY Comparison
Compare ABNB & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABNB | SNY |
|---|---|---|
| Founded | 2008 | 1994 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.4B | 119.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABNB | SNY |
|---|---|---|
| Price | $133.79 | $46.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 32 | 6 |
| Target Price | ★ $148.21 | $61.50 |
| AVG Volume (30 Days) | ★ 4.1M | 2.8M |
| Earning Date | 02-12-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 3.50% |
| EPS Growth | 47.91 | ★ 105.93 |
| EPS | 4.19 | ★ 8.67 |
| Revenue | $11,943,000,000.00 | ★ $53,890,648,839.00 |
| Revenue This Year | $11.79 | $1.73 |
| Revenue Next Year | $9.99 | $6.49 |
| P/E Ratio | $31.17 | ★ $5.27 |
| Revenue Growth | ★ 10.18 | N/A |
| 52 Week Low | $99.88 | $44.62 |
| 52 Week High | $163.93 | $60.12 |
Technical Indicators
Market Signals| Indicator | ABNB | SNY |
|---|---|---|
| Relative Strength Index (RSI) | 50.52 | 38.07 |
| Support Level | $127.83 | $45.25 |
| Resistance Level | $141.40 | $48.17 |
| Average True Range (ATR) | 3.96 | 0.71 |
| MACD | -1.18 | -0.19 |
| Stochastic Oscillator | 40.38 | 24.21 |
Price Performance
Historical ComparisonAbout ABNB Airbnb Inc.
Started in 2008, Airbnb is the world's largest online alternative accommodation travel agency; it also offers booking services for boutique hotels and experiences. Airbnb's platform offered over 8 million active accommodation listings as of Dec. 31, 2024. Listings from the company's 5 million-plus hosts are spread over almost every country in the world. In 2024, 45% of revenue was from North America, 37% from Europe, the Middle East, and Africa, 9% from Latin America, and 9% from Asia-Pacific. Transaction fees for online bookings account for all its revenue.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.